First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Green Thumb Industries: the story is balanced — Federal rescheduling progress - DEA moving cannabis from Schedule I to Schedule III would eliminate 280E tax burden…
★ Analysts see FY2027 revenue reaching $1.3B — +5.4% growth in a single year.
What Moves the Stock
1Federal rescheduling progress - DEA moving cannabis from Schedule I to Schedule III would eliminate 280E tax burden, potentially adding 15-20 percentage points to effective margins
2Same-store sales growth in mature markets - Illinois and Pennsylvania stores drive 60%+ of profitability, with comp growth tied to pricing stability and market share gains
4SAFE Banking Act progress - access to traditional banking and capital markets would reduce cost of capital from 12-15% to 6-8% and enable M&A activity
5Retail dispensary sales (~75% of revenue) - direct-to-consumer through RISE-branded stores with average ticket size $80-100
6Wholesale branded products (~25% of revenue) - Rythm flower, Dogwalkers pre-rolls, incredibles edibles sold to third-party dispensaries
7Ancillary revenue - cultivation consulting and licensing fees in limited markets
growth with event-driven catalyst overlay - Attracts investors seeking 20-30% annual revenue growth with asymmetric upside from federal…
High sensitivity through two channels: (1) Real estate costs - dispensary leases and cultivation facilities face 200-300bps premium…
Watch on earnings: DEA rescheduling timeline and Schedule III implementation details - Federal Register filings and public comment period closure dates, Illinois and Pennsylvania same-store sales trends - Monthly state regulatory data on total market size and Green Thumb market share, Wholesale flower pricing in key markets - Track $/lb in Illinois ($1,400-1,600), Pennsylvania ($1,200-1,400), Massachusetts ($1,000-1,200) as leading indicator of margin pressure.
One Sentence Summary:
Green Thumb Industries: the story is balanced — federal rescheduling progress - dea moving cannabis from schedule i to schedule iii would eliminate 280e tax burden.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.